News and Media

Press Releases


October 31, 2018
Casebia Therapeutics Expands Leadership Team with Addition of Dr. Adel Nada as Chief Medical Officer

May 30, 2018
Casebia Therapeutics Appoints Amy Jennings to Head its Regulatory Affairs


November 13, 2017
CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs

September 27, 2017
Casebia Therapeutics Announces License and Collaboration Agreements with Seattle Children’s Research Institute

September 8, 2017
Casebia Therapeutics Strengthens Leadership Team with Two Key Appointments

June 28, 2017
Casebia Therapeutics names Robin A. Walker as Vice President, Head of Legal

May 11, 2017
Casebia Therapeutics Expands Leadership Team

March 14, 2017
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement with MaxCyte


November 1, 2016
Casebia Therapeutics Announces Appointment of James W. Burns, Ph.D. as President and Chief Executive Officer

In the News


May 3, 2018
Evolving Industry Partnerships and Investments in Cell and Gene Therapies


September 15, 2017
Boston Business Journal: Casebia Head of Legal Robin Walker named one of the 50 Most Influential People of Color in Healthcare & Life Sciences

Social Media

During #ASH18, we & our collaborators @seattlechildren’s research institute will highlight findings around Conversion of T-Effector Cells to Immunosuppressive T-Regulatory-like Cells By #CRISPR/Cas9-Mediated Integration of a FOXP3 Transgene. Abstract here:

At the @MassBio Dinner on board #diversity this week w leaders from @jpmorgan, @NASA, #FrequencyTx @PolarisVC, Kaleido BioScience & Dimock Community Health Center. An illuminating and important conversation that we are pleased to be part of as we shape the future of our industry

See us on Twitter